PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Update

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totaling 385,403 shares, a growth of 63.2% from the April 30th total of 236,186 shares. Based on an average daily trading volume, of 733,200 shares, the short-interest ratio is currently 0.5 days. Currently, 33.3% of the shares of the stock are sold short.

PMGC Trading Down 6.6%

Shares of ELAB stock opened at $1.69 on Friday. The stock’s fifty day moving average is $3.02 and its two-hundred day moving average is $27.85. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.43 and a current ratio of 1.45. The firm has a market capitalization of $1.96 million, a P/E ratio of -0.01 and a beta of -0.27. PMGC has a fifty-two week low of $1.62 and a fifty-two week high of $309.12.

PMGC (NASDAQ:ELAB) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($11.22) earnings per share for the quarter. The business had revenue of $0.68 million during the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.